| abstract |
The present invention provides a drug for preventing or treating a disease associated with abnormal cytokine production or enhanced adhesion. The drug of the present invention contains 6- [2- (3,4-diethoxyphenyl) thiazol-4-yl] pyridine-2-carboxylic acid or a salt thereof. Diseases associated with abnormal cytokine production or increased adhesion include uveitis, endotoxin shock, ARDS, burns, acute phase of viral myocarditis, idiopathic dilated cardiomyopathy, transition from SIRS to organ failure, multiple organs Failure, hypergammaglobulinemia, SLE, multiple sclerosis, cancer metastasis suppression, monoclonal B cell abnormality, polyclonal B cell abnormality, atrial myxoma, castorman syndrome, primary glomerulonephritis, mesangial proliferative nephritis, Including cancer cachex, Rennert lymphoma, psoriasis, atopic dermatitis, Kaposi sarcoma associated with AIDS, postmenopausal osteoporosis, sepsis and hepatitis. [Selection figure] None |